<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03417180</url>
  </required_header>
  <id_info>
    <org_study_id>SilesianMUKOAiIT10</org_study_id>
    <nct_id>NCT03417180</nct_id>
  </id_info>
  <brief_title>SPI-guided Analgesia During FESS for Intraoperative Blood Loss</brief_title>
  <acronym>FESSSPI</acronym>
  <official_title>Comparative Study of Influence of Surgical Pleth Index Guided Total Intravenous Anaesthesia (TIVA) or Volatile Anaesthesia Using Sevoflurane or Desflurane on the Intraoperative Blood Loss During Functional Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Silesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Silesia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized trial is to assess the utility of Surgical Pleth Index (SPI) for
      monitoring pain perception intraoperatively and its influence on intraoperative blood loss,
      quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing
      functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or
      volatile anaesthesia using sevoflurane or desflurane
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intraoperative blood loss during FESS constitutes a major problem for a surgeon because it
      influences quality of surgical field. Each incident of haemorrhage makes the operator stop
      the procedure in order to bring back the optimal visualization of the intranasal anatomy. In
      the end it prolongs the time of procedure.

      Currently, intraoperative blood loss is estimated based on Boezaart Bleeding Scale (BBS) (0 -
      no bleeding (cadaveric conditions), 1 - Slight bleeding, no suctioning required, 2 - Slight
      bleeding, occasional suctioning required, 3 - Slight bleeding, frequent suctioning required;
      bleeding threatens surgical field a few seconds after suction is removed, 4 - Moderate
      bleeding, frequent suctioning required, and bleeding threatens surgical field directly after
      suction is removed, 5 - Severe bleeding, constant suctioning required; bleeding appears
      faster than can be removed by suction; surgical field severely threatened and surgery usually
      not possible).

      Recently, the Surgical Pleth Index (SPI) was added as a surrogate variable showing the
      nociception-antinociception balance into above mentioned parameters constituting a novel
      approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or
      tailor-made anaesthesia. SPI&gt;10 or any SPI&gt;50, were proposed to constitute the indication for
      administration of rescue analgesia intraoperatively.

      This study aims at evaluating utility of SPI-guided analgesia using remifentanil on the
      intraoperative blood loss, haemodynamic stability and time duration of surgery in patients
      undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol
      or volatile anaesthesia using sevoflurane or desflurane.

      Currently, FESS is most often performed using total intravenous anaesthesia (TIVA) which is
      by majority of anaesthesiologists believed to reduce the intraoperative blood loss compared
      to general anaesthesia using volatile anaesthetics, but current literature provides
      conflicting findings in this area if the sort of anaesthetic used influences quality of the
      surgical field.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood loss postoperatively</measure>
    <time_frame>end of operation,' assessment</time_frame>
    <description>the investigators will measure the amount of blood loss in the suction bag in millilitres (ml) using a syringe after operation of FESS is completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate stability intraoperatively</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>the investigators will measure heart rate during TIVAevery 5 minutes up to the end of the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SPI-guided pain perception intraoperatively</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure SPI values and adjust infusion speed of remifentanyl, in the case of delta SPI&gt;15 the speed of remifentanyl infusion will accelerate by 50%, intraoperatively, every 1 minute, up to the end of the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>condition of surgical field</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>the surgeon will assess the quality of surgical field using BBS when the operation of FESS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total consumption of propofol</measure>
    <time_frame>end of operation assessment</time_frame>
    <description>The investigators will measure the consumption of propofol intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total consumption of remifentanil</measure>
    <time_frame>end of operation assessment</time_frame>
    <description>The investigators will measure the consumption of remifentanyl intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of desflurane in end-expiratory gas</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure the concentration of desflurane in end-expiratory gas intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of sevoflurane in end-expiratory gas</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure the concentration of sevoflurane in end-expiratory gas intraoperatively</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Endoscopic Sinus Surgery</condition>
  <arm_group>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>concentration of sevoflurane in the exhalation gas will be maintained to ensure target SE 40, remifentanil will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, SPI will be monitored on-line; when delta SPI&gt;15, infusion speed of remifentanyl will be increased by 50% every 5 minutes until SPI value decreases back to baseline value</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>concentration of desflurane in the exhalation gas will be maintained to ensure target SE 40,remifentanil will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, SPI will be monitored on-line; when delta SPI&gt;15, infusion speed of remifentanyl will be increased by 50% every 5 minutes until SPI value decreases back to baseline value</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of propofol will be adjusted at target of SE 40, remifentanyl infusion will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, SPI will be monitored on-line; when delta SPI&gt;15, infusion speed of remifentanyl will be increased by 50% every 5 minutes until SPI value decreases back to baseline value</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>a rate of infusion of reminfentanil will be increased by 50% every 5 minutes, until SPI value decreases back to baseline level</description>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
    <other_name>Remifentanil infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>surgical pleth index</intervention_name>
    <description>every time SPI value increases by 15 a rate of infusion of reminfentanil will be increased by 50% every 5 minutes</description>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
    <other_name>SPI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written consent to participate in the study

          -  written consent to undergo functional endoscopic sinus surgery under general
             anaesthesia

          -  ASA (American Society of Anesthesiologists) I-III

        Exclusion Criteria:

          -  age under 18 years old

          -  allergy to propofol

          -  pregnancy

          -  any anatomical malformation making SE measurement impossible

          -  necessity of administration of vasoactive drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Przemysław O Jałowiecki, Ph. Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Silesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michał J Stasiowski, MD</last_name>
    <phone>696797922</phone>
    <phone_ext>0048</phone_ext>
    <email>mstasiowski.anest@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lech Krawczyk, Ph. Dr</last_name>
    <phone>323682341</phone>
    <phone_ext>0048</phone_ext>
    <email>lech.kraw@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Cafiero T, Cavallo LM, Frangiosa A, Burrelli R, Gargiulo G, Cappabianca P, de Divitiis E. Clinical comparison of remifentanil-sevoflurane vs. remifentanil-propofol for endoscopic endonasal transphenoidal surgery. Eur J Anaesthesiol. 2007 May;24(5):441-6. Epub 2007 Mar 12.</citation>
    <PMID>17376252</PMID>
  </reference>
  <reference>
    <citation>Sivaci R, Yilmaz MD, Balci C, Erincler T, Unlu H. Comparison of propofol and sevoflurane anesthesia by means of blood loss during endoscopic sinus surgery. Saudi Med J. 2004 Dec;25(12):1995-8.</citation>
    <PMID>15711683</PMID>
  </reference>
  <results_reference>
    <citation>Gruenewald M, Herz J, Schoenherr T, Thee C, Steinfath M, Bein B. Measurement of the nociceptive balance by Analgesia Nociception Index and Surgical Pleth Index during sevoflurane-remifentanil anesthesia. Minerva Anestesiol. 2015 May;81(5):480-9. Epub 2014 Jul 17.</citation>
    <PMID>25032676</PMID>
  </results_reference>
  <results_reference>
    <citation>Bhat Pai RV, Badiger S, Sachidananda R, Basappaji SM, Shanbhag R, Rao R. Comparison of surgical conditions following premedication with oral clonidine versus oral diazepam for endoscopic sinus surgery: A randomized, double-blinded study. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):250-6. doi: 10.4103/0970-9185.182112.</citation>
    <PMID>27275059</PMID>
  </results_reference>
  <results_reference>
    <citation>Marzban S, Haddadi S, Mahmoudi Nia H, Heidarzadeh A, Nemati S, Naderi Nabi B. Comparison of surgical conditions during propofol or isoflurane anesthesia for endoscopic sinus surgery. Anesth Pain Med. 2013 Sep;3(2):234-8. doi: 10.5812/aapm.9891. Epub 2013 Sep 1.</citation>
    <PMID>24282774</PMID>
  </results_reference>
  <results_reference>
    <citation>Cardesín A, Pontes C, Rosell R, Escamilla Y, Marco J, Escobar MJ, Bernal-Sprekelsen M. Hypotensive anaesthesia and bleeding during endoscopic sinus surgery: an observational study. Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1505-11. doi: 10.1007/s00405-013-2700-0. Epub 2013 Sep 20.</citation>
    <PMID>24052249</PMID>
  </results_reference>
  <results_reference>
    <citation>Cardesin A, Pontes C, Rosell R, Escamilla Y, Marco J, Escobar MJ, Bernal-Sprekelsen M. A randomised double blind clinical trial to compare surgical field bleeding during endoscopic sinus surgery with clonidine-based or remifentanil-based hypotensive anaesthesia. Rhinology. 2015 Jun;53(2):107-15. doi: 10.4193/Rhin14.185.</citation>
    <PMID>26030032</PMID>
  </results_reference>
  <results_reference>
    <citation>Drozdowski A, Sieśkiewicz A, Siemiatkowski A. [Reduction of intraoperative bleeding during functional endoscopic sinus surgery]. Anestezjol Intens Ter. 2011 Jan-Mar;43(1):45-50. Review. Polish.</citation>
    <PMID>21786531</PMID>
  </results_reference>
  <results_reference>
    <citation>Shen PH, Weitzel EK, Lai JT, Wormald PJ, Ho CS. Intravenous esmolol infusion improves surgical fields during sevoflurane-anesthetized endoscopic sinus surgery: a double-blind, randomized, placebo-controlled trial. Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e208-11. doi: 10.2500/ajra.2011.25.3701.</citation>
    <PMID>22185726</PMID>
  </results_reference>
  <results_reference>
    <citation>DeConde AS, Thompson CF, Wu EC, Suh JD. Systematic review and meta-analysis of total intravenous anesthesia and endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013 Oct;3(10):848-54. doi: 10.1002/alr.21196. Epub 2013 Jul 10. Review.</citation>
    <PMID>23843351</PMID>
  </results_reference>
  <results_reference>
    <citation>Gomez-Rivera F, Cattano D, Ramaswamy U, Patel CB, Altamirano A, Man LX, Luong A, Chen Z, Citardi MJ, Fakhri S. Pilot study comparing total intravenous anesthesia to inhalational anesthesia in endoscopic sinus surgery: novel approach of blood flow quantification. Ann Otol Rhinol Laryngol. 2012 Nov;121(11):725-32.</citation>
    <PMID>23193905</PMID>
  </results_reference>
  <results_reference>
    <citation>Blackwell KE, Ross DA, Kapur P, Calcaterra TC. Propofol for maintenance of general anesthesia: a technique to limit blood loss during endoscopic sinus surgery. Am J Otolaryngol. 1993 Jul-Aug;14(4):262-6.</citation>
    <PMID>8214320</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2018</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Silesia</investigator_affiliation>
    <investigator_full_name>Michał Stasiowski</investigator_full_name>
    <investigator_title>Principal Investigator, 2Department of Anaesthesiology and Intensive Therapy</investigator_title>
  </responsible_party>
  <keyword>Surgical Pleth Index (SPI)</keyword>
  <keyword>Intraoperative Blood Loss (IBL)</keyword>
  <keyword>Boezaart Bleeding Scale (BBS)</keyword>
  <keyword>Spectral Entropy (SE)</keyword>
  <keyword>Adequacy of Anaesthesia (AoA)</keyword>
  <keyword>Total Intravenous Anaesthesia (TIVA)</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Desflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>article in Laryngoscope in 2022, case reports</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

